EVOXIL-HP KIT combines three components with different mechanisms of action that are used together for Helicobacter pylori eradication.
Reducing gastric acid levels can support the activity of the antibacterial components and promote healing of the damaged gastric mucosa.
The kit may be prescribed for patients with confirmed H. pylori infection when the selected eradication regimen is appropriate for the patient's clinical situation and expected bacterial susceptibility.
Current clinical practice emphasizes consideration of local antibiotic resistance patterns and previous macrolide exposure. In areas with high clarithromycin resistance or in patients with risk factors for treatment failure, a healthcare professional may select an alternative eradication regimen.
The combination is used for eradication treatment of Helicobacter pylori infection in patients for whom this triple-therapy regimen has been prescribed by a healthcare professional.
Main treatment goals include:
Amoxicillin and clarithromycin act directly against susceptible bacteria, while pantoprazole inhibits the gastric H+/K+-ATPase in parietal cells, thereby reducing hydrochloric acid production.
The kit should be taken orally exactly as prescribed by a healthcare professional. The administration schedule depends on the specific H. pylori eradication regimen, so the dosage and treatment duration should not be changed without medical advice. The full prescribed course should be completed even if symptoms improve earlier. Missed doses may reduce treatment effectiveness and contribute to antibiotic resistance.
